Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 8 | Theoretical Biology and Medical Modelling

Fig. 8

From: Personalized life expectancy and treatment benefit index of antiretroviral therapy

Fig. 8

Effect of different drug efficacy and sensitiveites for the second-line regimen on HIV disease progression. a and b denote the CD4 T cell counts and viral loads, respectively. Black curve represents the first-line treatment only, purple and pink curves show the cases of switching from first-line regimen to the second-line regimen without and with improving drug efficacy, respectively. Parameter values for first-line regimen: \(\tau _{50}=50, \bar {\tau }_{50}=150, \eta =0.95\), \(\bar {\eta }=0.6, l=0.935\); Parameter values for the second-line regimen: \(\tau _{50}=30, \bar {\tau }_{50}=100\), \(\eta =0.95, \bar {\eta }=0.8\), l=0.92

Back to article page